Innopecia 1 mg. FC Tablets,
PDF Leaflet Revision Date: 30 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Temporarily delays hair loss and increases hair density in males with androgenetic alopecia.
Dosage (summary)
1 mg tablet daily, with or without food.
Onset of Action / Duration
Onset: 3 months, Duration: Reversible within 12 months after withdrawal.
Special Populations
- Paediatric population
- Elderly
Pregnancy & Breastfeeding
Contraindicated in women, especially during pregnancy due to risk to male fetus.
Key Drug Interactions
- 5u03b1-reductase inhibitors
- Cytochrome P450 3A4 inducers/inhibitors
Contraindications
- Hypersensitivity
- Women
- Children
Common side effects
- Decreased libido
- Depression
- Breast tenderness
- Impotence
Counselling Points
- Monitor for psychiatric symptoms
- Avoid exposure to pregnant women
- Report breast changes
Serious warnings
- Risk of male infertility
- Mood alterations
- Breast cancer risk
On This Page
Connecting to Document Server
Decrypting and optimizing pharmaceutical leaflet...
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
